Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland

Kelly Baillie; Tanja Mueller; Jiafeng Pan; Jennifer Laskey; Marion Bennie; Christine Crearie; Kimberley Kavanagh; Samantha Alvarez-Madrazo; David Morrison; Julie Clarke; Aileen Keel; David Cameron; Olivia Wu; Amanj Kurdi; Robert J. Jones

doi:10.1002/pds.4998

Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland

Kelly Baillie, Tanja Mueller, Jiafeng Pan, Jennifer Laskey, Marion Bennie, Christine Crearie, Kimberley Kavanagh, Samantha Alvarez-Madrazo, David Morrison, Julie Clarke, Aileen Keel, David Cameron, Olivia Wu, Amanj Kurdi, Robert J. Jones

科研成果: 期刊稿件 › 文章 › 同行评审

13 引用（Scopus）

源语言	英语
页（从-至）	653-663
页数	11
期刊	Pharmacoepidemiology and Drug Safety
卷	29
期	6
DOI	https://doi.org/10.1002/pds.4998
出版状态	已出版 - 6月 1 2020
已对外发布	是

!!!ASJC Scopus Subject Areas

药学（医学）
流行病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1002/pds.4998

其它文件与链接

引用此

Baillie, K., Mueller, T., Pan, J., Laskey, J., Bennie, M., Crearie, C., Kavanagh, K., Alvarez-Madrazo, S., Morrison, D., Clarke, J., Keel, A., Cameron, D., Wu, O., Kurdi, A., & Jones, R. J. (2020). Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland. Pharmacoepidemiology and Drug Safety, 29(6), 653-663. https://doi.org/10.1002/pds.4998

Baillie, K, Mueller, T, Pan, J, Laskey, J, Bennie, M, Crearie, C, Kavanagh, K, Alvarez-Madrazo, S, Morrison, D, Clarke, J, Keel, A, Cameron, D, Wu, O, Kurdi, A & Jones, RJ 2020, 'Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland', Pharmacoepidemiology and Drug Safety, 卷 29, 号码 6, 页码 653-663. https://doi.org/10.1002/pds.4998

@article{118defc6fcda4385a1839ca441a0e4d7,

title = "Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland",

keywords = "abiraterone, enzalutamide, metastatic castration-resistant prostate cancer, pharmacoepidemiology, real world, record linkage",

author = "Kelly Baillie and Tanja Mueller and Jiafeng Pan and Jennifer Laskey and Marion Bennie and Christine Crearie and Kimberley Kavanagh and Samantha Alvarez-Madrazo and David Morrison and Julie Clarke and Aileen Keel and David Cameron and Olivia Wu and Amanj Kurdi and Jones, {Robert J.}",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd.",

year = "2020",

month = jun,

day = "1",

doi = "10.1002/pds.4998",

language = "English",

volume = "29",

pages = "653--663",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland

AU - Baillie, Kelly

AU - Mueller, Tanja

AU - Pan, Jiafeng

AU - Laskey, Jennifer

AU - Bennie, Marion

AU - Crearie, Christine

AU - Kavanagh, Kimberley

AU - Alvarez-Madrazo, Samantha

AU - Morrison, David

AU - Clarke, Julie

AU - Keel, Aileen

AU - Cameron, David

AU - Wu, Olivia

AU - Kurdi, Amanj

AU - Jones, Robert J.

PY - 2020/6/1

Y1 - 2020/6/1

KW - abiraterone

KW - enzalutamide

KW - metastatic castration-resistant prostate cancer

KW - pharmacoepidemiology

KW - real world

KW - record linkage

UR - http://www.scopus.com/inward/record.url?scp=85084047722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084047722&partnerID=8YFLogxK

U2 - 10.1002/pds.4998

DO - 10.1002/pds.4998

M3 - Article

C2 - 32316077

AN - SCOPUS:85084047722

SN - 1053-8569

VL - 29

SP - 653

EP - 663

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 6

ER -

Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此